Novavax, Inc. (NVAX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria…
Source: Yahoo Finance
Sector & Industry
Novavax, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Novavax, Inc. at a Glance
| Company | Novavax, Inc. |
| Ticker | NVAX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $10.22 |
| Market cap | $1.69B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.53 |
| 52-week high | $11.97 |
| 52-week low | $6.20 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.45 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 4.29M |
| Shares outstanding | 164.95M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 749 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Novavax, Inc.'s current P/E ratio?
- Novavax, Inc. (NVAX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Novavax, Inc.'s market capitalisation?
- Novavax, Inc.'s market cap is $1.69B based on our latest snapshot. See how it ranks by market cap →
- What is NVAX's 52-week range?
- Over the past 52 weeks, NVAX has traded between $6.20 and $11.97. What does the 52-week range mean? →
- How volatile is Novavax, Inc. compared to the market?
- Novavax, Inc. has a beta of 2.45, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Novavax, Inc. pay a dividend?
- Novavax, Inc. does not currently pay a dividend according to our latest data.
- What exchange is NVAX listed on?
- NVAX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Novavax, Inc. in?
- Novavax, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →